Micro decides malignancy
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
Twitter ~ Facebook
Home / Technology News / 2010 / September 2010 / September 9, 2010
Micro-RNA decides malignancy of lung cancer
RSS / Print / Comments

Protein

Reportlinker Adds Global Milk Industry

Cellular defect that leads to cancer discovered

Why family history ups Alzheimers risk - especially from the maternal side

More on Protein

Lung Cancer

TTF therapy, chemo combo 'increase survival for lung cancer patients'

Surveys Highlight Advancing Confidence in Erbitux as Only Targeted Treatment to Increase Survival and Potential for Cure in Head and Neck Cancer

More on Lung Cancer

Technology News

Mercedes-Benz to come up with safer child seat soon
A safer and more advanced special seat in the car for your kid would soon be a reality-it was first shown in the ESF Experimental Safety Vehicle. ANI

Massive star goes supernova, smothered by its own dust
Astronomers using NASAs Spitzer Space Telescope have discovered that a giant star in a remote galaxy ended its life with a dust-shrouded whimper instead of the more typical bang. ANI

Genetic defect responsible for epilepsy and mental retardation found
Researchers have detected a genetic mutation responsible for severe mental retardation and epilepsy beginning at infancy. ANI

Micro-RNA decides malignancy of lung cancer

Micro-RNA is what determines the malignancy of lung cancer, found a new study.


Washington, Sep 9 : Micro-RNA is what determines the malignancy of lung cancer, found a new study.

Professor Dr. Heike Allgayer, head of a Clinical Cooperation Unit of DKFZ and UMM, is an expert for those cellular processes that lead to metastasis in cancer.

In recent years, scientists have discovered that production of many proteins is regulated by what are called micro-RNAs.

These RNA molecules, which consist of only about 23 building blocks, attach specifically to messenger RNAs, which contain the blueprints for proteins. In this way, they block the production of the respective protein.

"We believe that micro-RNAs also play an important role in metastasis and that they program cells in a way that leads to malignant growth," explained Heike Allgayer medical researcher.

In an international collaboration with researchers in Turin, Italy, Allgayer and her team used various cell lines of non-small cell lung cancer to investigate a particularly suspicious candidate called miR-200c and its role in malignant growth.

The research team found out that the less miR-200c is produced by a cell line, the higher its motility and its capacity to invade surrounding tissue.

When the researchers experimentally equipped the cancer cells with additional miR-200c, the amount of tissue-anchoring molecules on their surface increased and their invasive capacity became lower.

In animal experiments, these cells produced less metastasis.

A dreaded characteristic of non-small cell lung cancer is its resistance to chemotherapy and targeted anticancer drugs.

A lack of miR-200c also play a role here-therapy-resistant lung cancer cell lines that were experimentally equipped with miR-200c could subsequently be killed by the chemotherapy drug cisplatin and responded to cetuximab, a drug that block growth signals.

The researchers also discovered how the loss of miR-200c is brought about in cancer cells.

The researchers found that the lower the miR-200c level in the cancer cells, the more frequently metastasis had already begun.

"Our results clearly show a connection between a loss of miR-200c and transition to aggressive, invasive growth, metastasis and chemoresistance," summarized Heike Allgayer.

ANI

Link to this page

Suggested pages for your additional reading
AndhraNews.net on Facebook






© 2000-2017 AndhraNews.net. All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us